Thus, this high incidence rate is anticipated to boost the demand for prenatal tests. In addition, India has a heavy burden of genetic diseases.Various studies suggested that chromosomal abnormalities are found with a frequency of 1 in 166 newborns in the country, while trisomy 21 (Down syndrome) has a high incidence rate of 1 in 800 births, resulting in the birth of 32,000 newborns with Down syndrome every year.įamilies can benefit from accurate and early screening using NIPT to know about their baby’s genetic issue. Of all the countries, there is a substantial opportunity in China for non invasive prenatal screening, with nearly 14.65 million annual births and increasing number of high-risk pregnancies. Increasing incidence of chromosomal abnormalities is expected to accelerate market growth. The global non invasive prenatal testing market size is expected to reach USD 7.71 billion by 2030., expanding at a CAGR of 9.61% from 2022 to 2030.
Non Invasive Prenatal Testing Market Growth & Trends 13, 2022 (GLOBE NEWSWIRE) - announces the release of the report "Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Pregnancy Risk, By Method, By Technology, By Product, By Application, By End-use, By Region And Segment Forecasts, 2022 - 2030".
0 kommentar(er)
